COSCIENS Biopharma (CSCI) Gross Margin

Annual Gross Margin

41.07%
-17.41%-29.77%

01 December 2023

3-Year Change

-32.53%
CSCI annual gross profit margin is down -32.53% over the past 3 years

All-time High

75.00%
CSCI annual gross profit margin is currently -45.24% below its historical high of 75.00%

Annual Gross Margin Formula

Gross Profit
Revenue
✕ 100%
Annual Gross Profit$2.93 M
CSCI annual gross profit is $2.93 million
Annual Revenue$7.26 M
CSCI annual revenue is $7.26 million
Annual Net Margin-48.89%
CSCI annual net profit margin is -48.89%

CSCI Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Gross Margin

51.15%
+16.11%+45.98%

01 September 2024

1-Year Change

+254.72%
CSCI quarterly gross profit margin is up +254.72% year-on-year

1-Year Change

+254.72%
CSCI quarterly gross profit margin is up +254.72% year-on-year

All-time High

76.94%
CSCI quarterly gross profit margin is currently -33.52% below its historical high of 76.94%
Quarterly Gross Profit$957.00 K
CSCI quarterly gross profit is $957.00 thousand
Quarterly Revenue$1.87 M
CSCI quarterly revenue is $1.87 million
Quarterly Operating Margin-258.36%
CSCI quarterly operating profit margin is -258.36%
Quarterly Net Margin-307.59%
CSCI quarterly net profit margin is -307.59%

CSCI Quarterly Gross Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CSCI Gross Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+254.7%
3 y3 years-32.5%-30.5%
5 y5 years-2.9%+18.1%

CSCI Gross Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-45.2%-33.5%

COSCIENS Biopharma Gross Margin History

DateAnnualQuarterly
Sept 2024
-
51.15%(+46.0%)
June 2024
-
35.04%(-20.2%)
Mar 2024
-
43.93%(+204.6%)
Dec 2023
41.07%(-29.8%)
14.42%(-65.0%)
Sept 2023
-
41.24%(-28.0%)
June 2023
-
57.26%(+24.6%)
Mar 2023
-
45.95%(+23.6%)
Dec 2022
58.48%(-3.9%)
37.17%(-37.1%)
Sept 2022
-
59.11%(-15.0%)
June 2022
-
69.56%(+15.6%)
Mar 2022
-
60.19%(-18.2%)
Dec 2021
60.87%(+20.7%)
73.58%(+12.8%)
Sept 2021
-
65.21%(+9.0%)
June 2021
-
59.85%(+24.6%)
Mar 2021
-
48.02%(+20.3%)
Dec 2020
50.41%(+19.2%)
39.93%(-16.5%)
Sept 2020
-
47.81%(-13.8%)
June 2020
-
55.44%(-0.1%)
Mar 2020
-
55.51%(+28.1%)
Dec 2019
42.28%(-20.2%)
43.32%(+24.3%)
Sept 2019
-
34.85%(-27.2%)
June 2019
-
47.86%(+12.8%)
Mar 2019
-
42.44%(-21.8%)
Dec 2018
52.95%(-5.9%)
54.27%(+8.1%)
Sept 2018
-
50.22%(-11.7%)
June 2018
-
56.88%(+17.2%)
Mar 2018
-
48.52%(-13.7%)
Dec 2017
56.26%(-17.7%)
56.25%(+8.1%)
Sept 2017
-
52.02%(-18.2%)
June 2017
-
63.59%(+18.3%)
Mar 2017
-
53.75%(-18.8%)
Dec 2016
68.40%(+3.8%)
66.18%(+5.5%)
Sept 2016
-
62.74%(-13.2%)
June 2016
-
72.32%(+3.7%)
Mar 2016
-
69.74%(-9.4%)
Dec 2015
65.89%(+23.0%)
76.94%(+25.8%)
Sept 2015
-
61.17%(-14.7%)
June 2015
-
71.70%(+55.2%)
Mar 2015
-
46.20%(+31.8%)
Dec 2014
53.58%(+12.8%)
35.04%(-41.9%)
Sept 2014
-
60.31%(+1.5%)
June 2014
-
59.39%(+9.5%)
Mar 2014
-
54.24%(+32.6%)
Dec 2013
47.50%(+0.2%)
40.91%(-2.9%)
Sept 2013
-
42.15%(-26.3%)
June 2013
-
57.21%(+9.7%)
Mar 2013
-
52.17%(+47.1%)
Dec 2012
47.41%(-15.5%)
35.47%(-32.5%)
Sept 2012
-
52.52%(+16.3%)
June 2012
-
45.16%(-19.7%)
Mar 2012
-
56.23%(-4.6%)
Dec 2011
56.13%
58.94%(+42.1%)
Sept 2011
-
41.48%(-37.0%)
June 2011
-
65.85%(+9.6%)
DateAnnualQuarterly
Mar 2011
-
60.08%(+21.9%)
Dec 2010
45.12%(-6.9%)
49.29%(+12.8%)
Sept 2010
-
43.68%(-3.8%)
June 2010
-
45.42%(+12.8%)
Mar 2010
-
40.25%(+478.3%)
Dec 2009
48.47%(+59.4%)
6.96%(-82.9%)
Sept 2009
-
40.68%(-35.6%)
June 2009
-
63.14%(+11.4%)
Mar 2009
-
56.69%(-451.5%)
Dec 2008
30.40%(-36.6%)
-16.13%(-153.1%)
Sept 2008
-
30.38%(-13.1%)
June 2008
-
34.94%(+3.6%)
Mar 2008
-
33.74%(-7.7%)
Dec 2007
47.97%(+0.6%)
36.57%(+7.0%)
Sept 2007
-
34.17%(-38.1%)
June 2007
-
55.18%(-3.8%)
Mar 2007
-
57.35%(+3313.7%)
Dec 2006
47.70%(-17.9%)
1.68%(-97.0%)
Sept 2006
-
56.10%(-13.6%)
June 2006
-
64.90%(+26.3%)
Mar 2006
-
51.39%(-13.6%)
Dec 2005
58.13%(+21.8%)
59.46%(-6.8%)
Sept 2005
-
63.83%(+6.9%)
June 2005
-
59.70%(+41.2%)
Mar 2005
-
42.27%(+5.1%)
Dec 2004
47.73%(-17.9%)
40.23%(+11.6%)
Sept 2004
-
36.04%(-27.2%)
June 2004
-
49.51%(-14.5%)
Mar 2004
-
57.92%(-11.5%)
Dec 2003
58.16%(+14.1%)
65.44%(+7.4%)
Sept 2003
-
60.92%(+8.6%)
June 2003
-
56.07%(+21.5%)
Mar 2003
-
46.13%(+211.9%)
Dec 2002
50.98%(+39.2%)
14.79%(-77.0%)
Sept 2002
-
64.44%(+0.0%)
June 2002
-
64.41%(+74.6%)
Mar 2002
-
36.88%(+105.7%)
Dec 2001
36.63%(+1.8%)
17.93%(-60.8%)
Sept 2001
-
45.70%(+7.5%)
June 2001
-
42.51%(+30.6%)
Mar 2001
-
32.54%(-112.4%)
Dec 2000
36.00%(-7.0%)
-262.36%(-577.8%)
Sept 2000
-
54.91%(+9.8%)
June 2000
-
50.00%(>+9900.0%)
Mar 2000
-
0.00%(-100.0%)
Dec 1999
38.72%(-48.4%)
-229.75%(-444.6%)
Sept 1999
-
66.67%(-11.1%)
Dec 1998
75.00%(+331.3%)
74.98%(-0.0%)
June 1998
-
75.00%(+190.2%)
Dec 1997
17.39%(+4.3%)
25.84%(+80.8%)
Sept 1997
-
14.29%(-42.8%)
June 1997
-
25.00%(+25.0%)
Mar 1997
-
20.00%
Dec 1996
16.67%
-

FAQ

  • What is COSCIENS Biopharma annual gross profit margin?
  • What is the all time high annual gross margin for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly gross profit margin?
  • What is the all time high quarterly gross margin for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly gross margin year-on-year change?

What is COSCIENS Biopharma annual gross profit margin?

The current annual gross margin of CSCI is 41.07%

What is the all time high annual gross margin for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual gross profit margin is 75.00%

What is COSCIENS Biopharma quarterly gross profit margin?

The current quarterly gross margin of CSCI is 51.15%

What is the all time high quarterly gross margin for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly gross profit margin is 76.94%

What is COSCIENS Biopharma quarterly gross margin year-on-year change?

Over the past year, CSCI quarterly gross profit margin has changed by +36.73% (+254.72%)